Autem Therapeutics logo

Autem Therapeutics

EM-Powering Cancer Care

16 employees · est. 2017 · Hanover, United States

VS
Novocure logo

Novocure

Patient-forward: Aspiring to make a difference in cancer

1384 employees · est. 2000 · Switzerland

Novocure is the older company (2017 vs 2000); Novocure is the larger of the two.

Side-by-Side Comparison

Autem Therapeutics Novocure
Founded
2017 2000 older
Headquarters
Hanover, United States Switzerland
Employees
16 1384 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Series A Post Ipo Debt
Total Funding
$10.00M $1.07B
Funding Rounds
1 7
Services
Cancer treatment using Autem Therapy, Supply of AutEMsys™ devices, Research and development in biotechnology Not tracked yet
Target Customers
Cancer Patients, Healthcare Providers, Remote Medical Facilities Not tracked yet
Taxonomy
Oncology Therapy, Bioelectric Treatment, Non-invasive Treatment, Non-toxic Therapy, HCC, Liver Cancer, Solid Tumor Cancers, FDA Breakthrough Designation, AutEMsys™ Therapy, Electromagnetic Frequencies, Clinical Feasibility Studies, FDA Investigational Device Exemption (IDE), Pivotal Clinical Trials, Cancer Treatment Innovation, Medical Device Development Oncology, Cancer Therapy, Tumor Treating Fields, Glioblastoma Treatment, Neuro-oncology, Clinical Trials, Global Operations, Innovative Therapies, Cancer Research, Anti-mitotic Treatment
Website
autemtherapeutics.com novocure.com
Autem Therapeutics logo

About Autem Therapeutics

Autem Therapeutics, operating under the slogan "EM-Powering Cancer Care," is a pioneering company in the Biotechnology and Health Care sectors. Based in Hanover, NH, USA, and founded in 2017, this privately held firm is at the forefront of developing a novel, non-invasive treatment platform targetin...

Novocure logo

About Novocure

Novocure is a global oncology company with the mission of extending survival in aggressive forms of cancer. The company's innovative therapy, Tumor Treating Fields, is aimed at making a difference in cancer treatment. Novocure's commercialized products are approved in certain countries for the treat...

We will tell you when either one moves

BounceWatch watches Autem Therapeutics and Novocure for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Autem Therapeutics and Novocure — by email.

Frequently Asked Questions

Autem Therapeutics — EM-Powering Cancer Care. Novocure — Patient-forward: Aspiring to make a difference in cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Autem Therapeutics has raised $10.00M while Novocure has raised $1.07B.
Autem Therapeutics and Novocure operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Autem Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Autem Therapeutics on 12 Sep 2024, and Novocure on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy